Abstract
BackgroundInterleukin-1 (IL-1) is a potent mediator of of inflammation. Kineret is a recombinant, non-glycosylated form of the human IL-1 receptor antagonist (IL-1Ra). The safety profile of Kineret is well documented...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
